Kim JH, Mogasale V, Burgess C, Wierzba TF. Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study. Vaccine 2016, 34(18): 2113-2120.

Burgess C, Burgess A. Modeling risk to DoD Service members of stopping blanket mandatory polio vaccination. Final report to the Naval Health Research Center 2016.

Burgess C, Peace A, Everett R, Allegri B, Garman P. Computational modeling of interventions and protective thresholds to prevent disease transmission in deploying populations. Computational and Mathematical Methods in Medicine 2014; doi:10.1155/2014/785752.

Burgess C, Peace A, Everett R, Allegri B, Woolpert T. Modeling herd immunity for hepatitis B in deployed US military populations and Modeling herd immunity for rubella in deployed US military populations. Final reports to the Naval Health Research Center 2013.

Burgess C, Peace A, Everett R, Woolpert T. Modeling risk of measles, rubella and varicella transmission from deployed US military to local populations. Final report to the Naval Health Research Center 2013.

Burgess C, Burgess A, Peace A, Everett R, Woolpert T. Modeling outbreak response interventions for varicella and hepatitis A in deployed US military populations. Final report to the Naval Health Research Center 2013.

Burgess C, Burgess A, Everett R, Paganucci L, Pittman P. Modeling outbreak response interventions for smallpox in deployed US military populations. Final report to the US Army Medical Research Institute of Infectious Diseases 2013.

Burgess C, Gaff H, Peace A, Burgess A, Thomas SJ, Jarman RG. Modeling the potential impact of dengue transmission and vaccination on DoD forces. Final report to the Walter Reed Army Institute of Research 2013.

Mogasale M, Levin A, Maskery B, DeRoeck D, Kim YE, Clemens J, Lopez AL, Burgess C, Wierzba T. Oral cholera vaccines to control endemic disease: An economic and epidemiological modelling analysis. The Lancet 2013; 382: 6.

Babigumira J, Levin A, Burgess C, Garrison LP, Bauch C, Braka F, Mbabazi WB, Nabyonga JO, Simons E, Dabbagh A. Assessing the cost- effectiveness of measles elimination in Uganda: Local impact of a global eradication program. Journal of Infectious Diseases 2011; 204 (Suppl 1): S107-S115.

Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, Dabbagh A. Global eradication of measles: An epidemiologic and economic evaluation. Journal of Infectious Diseases 2011; 204(Suppl 1): S98-S106.

LaRee T, Gaff H, Burgess C, Sow S, Gravitt P, Tracy JK. Estimating the impact of human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. Clinical Infectious Diseases 2011; 52(5): 641-645.

Gaff H, Burgess C, Jackson J, Niu T, Papelis Y, Hartley D. Mathematical model to assess the relative effectiveness of Rift Valley fever countermeasures. International Journal of Artificial Life Research 2011; 2(2): 1-18.

Levin A, Burgess C, Garrison LP, Bauch C, Babigumira J, Simons E, Dabbagh A. Economic evaluation of measles eradication study: Results for six countries and by income groups. Final report to the World Health Organization 2010.

Burgess C. Cholera Investment Case Appendix 8: Description of impact analysis and assumptions. Final report to International Vaccine Institute 2010.

Gaff H, Burgess C. Modeling tick-borne disease: An individual-based model. Final report to Old Dominion University 2009.

Levin A, Burgess C. Decision analysis to guide policy on the introduction of a routine second dose of measles vaccine. Final report to the World Health Organization 2009.

Burgess C, Niu T, Gaff H, Hartley D. Modeling control of Rift Valley fever. Final report to Georgetown University 2008.

Burgess C, Drapeau M, Armstong R. SHOCK and Awe: An ecological framework for counterinsurgency operations, analogies with ecology. Technical report to the National Defense University 2008

Nielson R, McDonald L, Sullivan J, Burgess C, Johnson DS, Johnson DH, Bucholtz S, Hyberg S, Howlin S. Estimating response of ring-necked pheasant (Phasianus Colchicus) to the Conservation Reserve Program. The Auk 2008; 125(2): 434-444.

Burgess C, Burgess A, Sullivan D. DoDIM-Medic: Department of Defense Infection Modeling for military medical personnel. Final report to Quantum Leap Health Sciences 2007.

Burgess C, Burgess A, Sullivan D. DoDIM-OPLAN: Department of Defense Infection Modeling for operational plans. Final report to Quantum Leap Health Sciences 2007.

Burgess C. Modeling Immunization Technologies. Technical report to Booz Allen Hamilton 2007.

Burgess C. Utilization of predictive mathematical epidemiological modeling in crisis preparedness exercises. In: Zeng D., et al. (Eds.). Intelligence and Security Informatics: Biosurveillance. Berlin: Springer, 2007.

Burgess C, Burgess A. DoDIM v.2.0: Department of Defense Infection Modeling malaria module. Final report to Quantum Leap Health Sciences 2006.

Burgess C, Burgess A, Sullivan D, Chui B. DoDIM v.2.0: Department of Defense Infection Modeling. Final report to Potomac Institute for Policy Studies 2006.

Burgess C. Uncertainty in incidence and underreporting multipliers. Technical whitepaper to University of Maryland 2006.

Burgess C, Burgess A, Sullivan D, Chui B. DoDIM: Department of Defense Influenza Modeling proof-of-concept summary. Final report to Potomac Institute for Policy Studies 2005.

Burgess C. Exploration of appropriate model forms for transmission system analysis of endemic cryptosporidiosis. Final report to EPA 2005.

Burgess C, Burgess A, Sullivan D. WHO-VS Vaccination Simulator. Final report to the World Health Organization 2004.

Burgess C. Schistosomiasis (Bilharzia).Technical report to IDRAM 2004.